Jeremy S Torrisi
Overview
Explore the profile of Jeremy S Torrisi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
554
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Nores G, Ly C, Cuzzone D, Kataru R, Hespe G, Torrisi J, et al.
Nat Commun
. 2018 May;
9(1):1970.
PMID: 29773802
T cell-mediated responses have been implicated in the development of fibrosis, impaired lymphangiogenesis, and lymphatic dysfunction in secondary lymphedema. Here we show that CD4 T cells are necessary for lymphedema ...
2.
Gardenier J, Kataru R, Hespe G, Savetsky I, Torrisi J, Nores G, et al.
Nat Commun
. 2017 Feb;
8:14345.
PMID: 28186091
Secondary lymphedema, a life-long complication of cancer treatment, currently has no cure. Lymphedema patients have decreased quality of life and recurrent infections with treatments limited to palliative measures. Accumulating evidence...
3.
Gardenier J, Hespe G, Kataru R, Savetsky I, Torrisi J, Nores G, et al.
JCI Insight
. 2016 Oct;
1(15):e84095.
PMID: 27699240
Development of novel treatments for lymphedema has been limited by the fact that the pathophysiology of this disease is poorly understood. It remains unknown, for example, why limb swelling resulting...
4.
Nitti M, Hespe G, Kataru R, Nores G, Savetsky I, Torrisi J, et al.
J Physiol
. 2016 Sep;
594(23):7073-7087.
PMID: 27619475
Key Points: Obesity induces lymphatic leakiness, decreases initial lymphatic vessel density, impairs collecting vessel pumping and decreases transport of macromolecules. Obesity results in perilymphatic inducible nitric oxide synthase (iNOS) expression...
5.
Hespe G, Kataru R, Savetsky I, Nores G, Torrisi J, Nitti M, et al.
J Physiol
. 2016 Mar;
594(15):4267-82.
PMID: 26931178
Key Points: Obesity results in perilymphatic inflammation and lymphatic dysfunction. Lymphatic dysfunction in obesity is characterized by decreased lymphatic vessel density, decreased collecting lymphatic vessel pumping frequency, decreased lymphatic trafficking...
6.
Torrisi J, Hespe G, Cuzzone D, Savetsky I, Nitti M, Gardenier J, et al.
Sci Rep
. 2016 Jan;
6:19817.
PMID: 26796537
Although recent studies have shown that obesity decreases lymphatic function, the cellular mechanisms regulating this response remain unknown. In the current study, we show that obesity results in perilymphatic accumulation...
7.
Savetsky I, Albano N, Cuzzone D, Gardenier J, Torrisi J, Nores G, et al.
J Invest Dermatol
. 2015 Jul;
135(11):2742-2752.
PMID: 26176761
Obesity is a major risk factor for inflammatory dermatologic diseases, including atopic dermatitis and psoriasis. In addition, recent studies have shown that obesity impairs lymphatic function. As the lymphatic system...
8.
Savetsky I, Ghanta S, Gardenier J, Torrisi J, Nores G, Hespe G, et al.
PLoS One
. 2015 Jun;
10(6):e0126908.
PMID: 26039103
Lymphangiogenesis is the process by which new lymphatic vessels grow in response to pathologic stimuli such as wound healing, inflammation, and tumor metastasis. It is well-recognized that growth factors and...
9.
Albano N, Cuzzone D, Ghanta S, Aschen S, Farias-Eisner G, Savetsky I, et al.
Plast Reconstr Surg
. 2015 May;
133(3 Suppl):161-162.
PMID: 25942257
No abstract available.
10.
Cuzzone D, Albano N, Ghanta S, Aschen S, Savetsky I, Gardenier J, et al.
Plast Reconstr Surg
. 2015 May;
133(3 Suppl):159-160.
PMID: 25942255
No abstract available.